Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

Australia: THC completes Queensland R&D and cultivation facility

The Hydroponics Company has successfully completed stage 1 of its R&D facility and growing capability in Queensland. Since October 2017, THC has increased the investment in, and focus upon, the development of the Queensland site.

The site has been developed to allow for increasing demand for high quality medicinal cannabis products in both local and export markets. Stage 1 of the development includes greenhouses for indoor cultivation and growth of medicinal cannabis, a drying and shredding facility for the initial processing of the dried plants, and an extraction laboratory for the processing of crude extract from the shredded plants.

The site will also provide an onsite laboratory for development of new strains, as well as testing and quality control of harvested products. The current site, when fully optimized, will be scalable to meet the demands of a growing market.

THC plans to vertically integrate along the industry value chain by producing a high quality, processed product that will differentiate THC from companies focused solely upon the production of medicinal cannabis as an agricultural commodity. Stage 2 of the Strategic Growth plan for THC is to further process the raw material (dry bud) into higher value medicinal cannabis oils for use in both Australian and international patients. These products will be provided to approved Australian patients through the National Access Cannabis clinics in Australia as a branded product, along with other premium products from international partners. Conversations have commenced with National Access Cannabis, Canada to supply high quality Canndeo products to supplement NAC’s existing product portfolio. As at 31 August 2017, NAC Canada had in excess of 8,500 members.

David Radford of THC states: "The Board recognises the significant contribution of the Queensland team to the growth of the business. This small team has contributed significantly to the development and submission of the licence applications to the ODC, whilst managing the build out. We look forward to being granted the manufacturing licence and final approvals in order to commence the growing and manufacturing program of high quality medicinal products”.

For more information:
The Hydroponics Company
Suite 305, Level 3, 35 Lime Street
Sydney, NSW 2000 Australia
www.thcl.com.au
Publication date: